Explore the ground-breaking 3-year results of Nivolumab combined with chemotherapy! This innovative treatment shows promising outcomes in patients with advanced cancers. Nivolumab, an immune checkpoint inhibitor, works synergistically with chemotherapy to enhance survival rates and improve the quality of life. Tune in to see how this combination is revolutionizing cancer care and what these results mean for future treatment strategies.
- #general surgery
- #pharmacology
- #general medicine
- #psych
- #rheumatology
- #pathology
- #radiology
- #anaesthesia
- #psychiatry
- #fmt
- #emergency medicine
- #academics
- #nursing
- #pharmacy
- #trichology
- #andrology
- #orthopaedics
- #critical care
- #dermatology
- #dentistry
- #oncology
- #business
- #gastroenterology
- #nephrology
- #diagnostics
- #urology
- #ophthalmology
- #gynaecology - ivf
- #pediatrics
- #neurology
- #ent
- #pulmonology
- #family health
- #cardiology
- #endo-diabetology
1
Comment
Like
Comments
Save
Share
Comments
Add a comment
Dr. Ramesh Kumar
Active Contributor
Nice information